Literature DB >> 28062968

Enigmas, priorities and opportunities in cancer epidemiology.

Hans-Olov Adami1,2,3, Olof Nyrén4.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28062968     DOI： 10.1007/s10654-016-0218-7

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN： 0393-2990            Impact factor:   8.082


× No keyword cloud information.
  40 in total

1.  The decline in the incidence of stomach cancer in Sweden 1960-1984: a birth cohort phenomenon.

Authors:  L E Hansson; R Bergström; P Sparén; H O Adami
Journal:  Int J Cancer       Date:  1991-02-20       Impact factor: 7.396

2.  Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness.

Authors:  H Gilbert Welch; Philip C Prorok; A James O'Malley; Barnett S Kramer
Journal:  N Engl J Med       Date:  2016-10-13       Impact factor: 91.245

Review 3.  Power failure: why small sample size undermines the reliability of neuroscience.

Authors:  Katherine S Button; John P A Ioannidis; Claire Mokrysz; Brian A Nosek; Jonathan Flint; Emma S J Robinson; Marcus R Munafò
Journal:  Nat Rev Neurosci       Date:  2013-04-10       Impact factor: 34.870

4.  Overdiagnosis of invasive breast cancer due to mammography screening: results from the Norwegian screening program.

Authors:  Mette Kalager; Hans-Olov Adami; Michael Bretthauer; Rulla M Tamimi
Journal:  Ann Intern Med       Date:  2012-04-03       Impact factor: 25.391

5.  Enigmatic sex disparities in cancer incidence.

Authors:  Gustaf Edgren; Liming Liang; Hans-Olov Adami; Ellen T Chang
Journal:  Eur J Epidemiol       Date:  2012-01-03       Impact factor: 8.082

6.  Aiming High--Changing the Trajectory for Cancer.

Authors:  Douglas R Lowy; Francis S Collins
Journal:  N Engl J Med       Date:  2016-04-04       Impact factor: 91.245

7.  Effect of screening mammography on breast-cancer mortality in Norway.

Authors:  Mette Kalager; Marvin Zelen; Frøydis Langmark; Hans-Olov Adami
Journal:  N Engl J Med       Date:  2010-09-23       Impact factor: 91.245

8.  Marked increase in the incidence rate of esophageal adenocarcinoma in a high-risk area for esophageal cancer.

Authors:  Fatemeh Ghasemi-Kebria; Gholamreza Roshandel; Shahryar Semnani; Ramin Shakeri; Masoud Khoshnia; Mohammad Naeimi-Tabiei; Shahin Merat; Reza Malekzadeh
Journal:  Arch Iran Med       Date:  2013-06       Impact factor: 1.354

9.  Variations of gastric corpus microbiota are associated with early esophageal squamous cell carcinoma and squamous dysplasia.

Authors:  Dariush Nasrollahzadeh; Reza Malekzadeh; Alexander Ploner; Ramin Shakeri; Masoud Sotoudeh; Saman Fahimi; Siavosh Nasseri-Moghaddam; Farin Kamangar; Christian C Abnet; Björn Winckler; Farhad Islami; Paolo Boffetta; Paul Brennan; Sanford M Dawsey; Weimin Ye
Journal:  Sci Rep       Date:  2015-03-06       Impact factor: 4.379

Review 10.  False-positive results in cancer epidemiology: a plea for epistemological modesty.

Authors:  Paolo Boffetta; Joseph K McLaughlin; Carlo La Vecchia; Robert E Tarone; Loren Lipworth; William J Blot
Journal:  J Natl Cancer Inst       Date:  2008-07-08       Impact factor: 13.506
View more
  3 in total

1.  A note of thanks and an invitation.

Authors:  Albert Hofman
Journal:  Eur J Epidemiol       Date:  2018-12       Impact factor: 8.082

2.  The Rotterdam Study: 2018 update on objectives, design and main results.

Authors:  M Arfan Ikram; Guy G O Brusselle; Sarwa Darwish Murad; Cornelia M van Duijn; Oscar H Franco; André Goedegebure; Caroline C W Klaver; Tamar E C Nijsten; Robin P Peeters; Bruno H Stricker; Henning Tiemeier; André G Uitterlinden; Meike W Vernooij; Albert Hofman
Journal:  Eur J Epidemiol       Date:  2017-10-24       Impact factor: 8.082

3.  Advanced parental age as risk factor for childhood acute lymphoblastic leukemia: results from studies of the Childhood Leukemia International Consortium.

Authors:  Eleni Th Petridou; Marios K Georgakis; Friederike Erdmann; Xiaomei Ma; Julia E Heck; Anssi Auvinen; Beth A Mueller; Logan G Spector; Eve Roman; Catherine Metayer; Corrado Magnani; Maria S Pombo-de-Oliveira; Sameera Ezzat; Michael E Scheurer; Ana Maria Mora; John D Dockerty; Johnni Hansen; Alice Y Kang; Rong Wang; David R Doody; Eleanor Kane; Waffa M Rashed; Nick Dessypris; Joachim Schüz; Claire Infante-Rivard; Alkistis Skalkidou
Journal:  Eur J Epidemiol       Date:  2018-05-14       Impact factor: 8.082
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.